ANRO
Alto Neuroscience, Inc.
24.80$
-2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -100.0% | – | – | – | |
| – | +135.9% | +9.1% | +34.6% | +31.7% | |
| – | -626.2% | – | – | – | |
| – | +183.0% | +27.9% | +55.1% | -2.9% | |
| – | +41.3% | +36.6% | +187.5% | -4.0% | |
| – | +138.0% | +31.1% | +80.1% | -3.5% | |
| – | – | – | – | – | |
| – | – | – | +0.4% | +79.6% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.